Redhill Biopharma | D:发行公告
02/05 21:02
Redhill Biopharma | SC 13G:超过5%持股股东披露文件-Mitchell P. Kopin(4.0%),Daniel B. Asher(4.0%)等
02/03 05:15
Redhill Biopharma | SC 13G:超过5%持股股东披露文件-CVI Investments, Inc.(5.9%),Heights Capital Management, Inc.(5.9%)
02/01 23:26
Redhill Biopharma | SC 13G/A:超过5%持股股东披露文件(修正)-Empery Asset Management, LP(3.19%),Ryan M. Lane(3.19%)等
01/08 13:00
Redhill Biopharma | SC 13G/A:超过5%持股股东披露文件(修正)
01/02 13:00
Redhill Biopharma | D:发行公告
2023/10/13 04:05
Redhill Biopharma | D:发行公告
2023/08/08 04:05
Redhill Biopharma | SC 13G:超过5%持股股东披露文件-Empery Asset Management, LP(6.12%),Ryan M. Lane(6.12%)等
2023/01/13 21:04
Redhill Biopharma | SC 13G:超过5%持股股东披露文件
2023/01/04 22:09
Redhill Biopharma | SC 13G:超过5%持股股东披露文件-Cosmo Pharmaceuticals N.V.(13.2%),Cosmo Technologies Ltd.(13.2%)
2022/03/08 06:25
Redhill Biopharma | SC 13G/A:超过5%持股股东披露文件(修正)-Ibex Investors LLC(0.3%),Justin B. Borus(0.3%)等
2022/01/28 05:31
Redhill Biopharma | D:发行公告
2021/11/23 05:59
Redhill Biopharma | SC 13G/A:超过5%持股股东披露文件(修正)
2021/01/16 00:19
Redhill Biopharma | SC 13G/A:超过5%持股股东披露文件(修正)
2020/02/13 22:55
Redhill Biopharma | SC 13G/A:超过5%持股股东披露文件(修正)
2020/01/28 05:27
Redhill Biopharma | D:发行公告
2019/11/07 03:34
Redhill Biopharma | SC 13G:超过5%持股股东披露文件
2019/06/18 05:01
Redhill Biopharma | SC 13G/A:超过5%持股股东披露文件(修正)
2019/02/20 01:53
Redhill Biopharma | SC 13G:超过5%持股股东披露文件
2019/02/19 22:30
Redhill Biopharma | SC 13G/A:超过5%持股股东披露文件(修正)
2019/02/15 00:43
暂无数据
暂无数据